Back to today’s briefing

Story perspectives

Revolutionary Lipid Nanoparticles Break Blood-Brain Barrier for Disease Treatment

2/18/2025

49 6

Summary

Story summary

Researchers at the Icahn School of Medicine have made a groundbreaking advancement with lipid nanoparticles (BLNPs) that can transport mRNA across the blood-brain barrier through intravenous injection. This innovation holds promise for treating devastating neurological diseases such as Alzheimer's and ALS, with the MK16 formulation proving to be more effective than current FDA-approved options, opening doors for future clinical breakthroughs.

1 of 1

Story summary

Researchers at the Icahn School of Medicine have made a groundbreaking advancement with lipid nanoparticles (BLNPs) that can transport mRNA across the blood-brain barrier through intravenous injection. This innovation holds promise for treating devastating neurological diseases such as Alzheimer's and ALS, with the MK16 formulation proving to be more effective than current FDA-approved options, opening doors for future clinical breakthroughs.